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Introduction 7 First, we tested whether the published relationship between biodiversity and disease was 121 linear or nonlinear by comparing intercept-only, linear, second-order, and third-order polynomial 122 regression models for all biodiversity-disease relationships, selecting the best-fitting model using 123 AIC (Table S1 ). Importantly, these models were only based on the data presented in each study 124 and thus did not constrain the biodiversity-disease relationship to the origin (see "Do missing 125 data at low and high diversity bias studies to report dilution effects?" section below). Out of the 126 231 studies that included more than three levels of biodiversity, 63% were best fit by a linear, 127 second-order, or third-order polynomial model (i.e., exhibited a relationship between biodiversity 128 and disease). Of these studies, biodiversity-disease relationships were most commonly non-129 linear, as predicted. More specifically, 60% exhibited non-linear relationships (either second-or 130 third-order polynomial), while 8% exhibited linear amplification effects, and 32% exhibited 131 rank correlation coefficient (r) approaches one for monotonic, positive relationships, and 144 approaches negative one for monotonic, negative relationships. We therefore used r to define 145 monotonic amplification (r>0, p<0.05), monotonic dilution (r<0, p<0.05), and non-significant 146 or non-monotonic relationships (p>0.05). Consistent with the previous analysis, 15% of the 231 147 relationships exhibited monotonic amplification effects, 31% exhibited monotonic dilution 148 effects, and 54% exhibited non-significant or non-monotonic relationships. 149
Given that non-linear and non-monotonic biodiversity-disease relationships are most 150 common and that amplification effects might predominate when these relationships are left-151 skewed or asymptotic, whereas dilution might predominate when they are right-skewed (12), we 152 next assessed the skew of each biodiversity-disease relationship. To do so, we fit a smoothing 153 spline to each published biodiversity-disease relationship, that was not constrained to pass 154 through the origin, and then calculated Pearson's skewness from the shape of the estimated 155 curve, excluding studies where there was no relationship (i.e., where the slope of the curve was 156 not significantly different from zero; n=29). As expected, Pearson's skewness and Spearman 157 rank correlation were in agreement when studies exhibited monotonic biodiversity-disease 158 relationships. Specifically, studies exhibiting monotonic dilution effects were significantly right-159 skewed (p<0.001), and studies exhibiting monotonic amplification effects were significantly left-160 skewed (p<0.001; Fig. 2 ). Studies exhibiting non-significant or non-monotonic relationships 161 based on Spearman rank correlation were not significantly skewed (p=0.59), indicating that non-162 monotonic biodiversity-disease relationships, on average, showed similar levels of amplification 163 or dilution. These results were qualitatively similar for the analysis comparing intercept-only, These results support the hypothesis that the shape of biodiversity-disease relationships 166 might be nonlinear (12, 20) and might therefore have implications for biodiversity conservation. 167
Specifically, because biodiversity-disease relationships are often nonlinear, where an individual 168 system falls along a biodiversity gradient might influence whether that system experiences 169 amplification or dilution. Thus, understanding how an individual conservation action will alter 170 biodiversity can have a large impact on whether that action is expected to increase or decrease 171 wildlife and human disease risk. 172 173
Is the biodiversity-disease relationship moderated by spatial scale? 174
Second, we tested whether the shape and direction of the biodiversity-disease relationship 175 was moderated by spatial scale, measured as the spatial extent of each study. Spatial extent 176 represents the total area over which a study is conducted, including all measures of biodiversity 177 and disease for a given study. Spearman's r, which measures the monotonicity and direction of 178 association between biodiversity and disease, was positively associated with spatial extent 179 (p<0.001; marginal R 2 =0.34; Fig 3a) , with monotonic dilution effects most commonly occurring 180 at small to intermediate spatial scales and monotonic amplification effects most commonly 181 occurring at the largest spatial scales. Incorporating the shape of non-monotonic relationships did 182 not alter this result; Pearson's skewness was significantly associated with spatial extent 183 (p<0.001; marginal R 2 =0.22; Fig 3b) , with right-skewed relationships (indicating more dilution) 184 occurring at small to intermediate spatial scales and left-skewed relationships (indicating more 185 amplification) occurring at large spatial scales. 186
Dilution generally occurred within an ecosystem, at spatial extents <100 km 2 (roughly the 187 size of a small city), whereas amplification generally occurred across ecosystems, in studies 188 occupying >1,000,000 km 2 (roughly the size of France and Spain combined). These results 189 therefore indicate that the overall disease burden in one ecosystem can be higher than another 190 because its native biodiversity is higher, but if this ecosystem has its biodiversity lowered, 191 disease could still worsen. Consequently, these results indicate that within individual countries, 192 conserving biodiversity might improve human, wildlife, and ecosystem health. 193
This dependence of biodiversity-disease relationships on spatial scale may be an indicator of 194 a more general mechanism of disease amplification. Notably, comparison of biodiversity-disease 195 relationships within an ecosystem often include many of the same host species (e.g., 29), whereas 196 comparisons of biodiversity across ecosystems tend to include distinct sets of host species (e.g., 197 30). Thus, measuring the degree to which host-species turnover (β diversity) drives disease 198 amplification could help clarify why amplification occurs at large spatial extents, and possibly 199 help predict when amplification will be more common, in general. 200
These results reveal a strong, widespread association between the shape of biodiversity-201 disease relationships and the spatial scale of observations, supporting the hypothesis that 202 biodiversity-disease relationships are scale-dependent (7, 23). Importantly, however, not every 203 small-scale study exhibited dilution, nor did every large-scale study exhibit amplification. As an 204 example, in a global survey of human disease burden, disease generally increased with 205 increasing diversity, but human schistosomiasis was negatively correlated with diversity (30) 206 and, at small spatial scales, biodiversity can amplify disease via a sampling effect, if species are 207 added randomly with respect to host competence and transmission is frequency-dependent (31). 208
We tested whether several ecological factors could explain variation in the effect of spatial 209 scale on the shape of biodiversity-disease relationships. Specifically, we tested whether the effect humans vs. wildlife, (ii) macro-vs. microparasites, (iii) parasites with complex vs. direct 212 lifecycles, and (iv) observational vs. manipulative studies. We found no evidence that the effect 213 of spatial scale on biodiversity-disease relationships depended on any of these factors (Table 1) . 214
Thus, the effect of spatial scale on biodiversity-disease relationships was generally robust across 215 all ecological contexts examined. However, we encourage caution in interpreting these results, as 216 there was multicollinearity in these analyses. Specifically, observational studies and studies of 217 human pathogens both tended to occur at larger spatial scales than manipulative studies and 218 studies of wildlife pathogens ( Fig. S3 ). Consequently, we cannot rule out the possibility that 219 these results could change if future studies filled these research gaps, allowing tests of these 220 context dependencies to be less collinear. 221
222

Do missing data at low and high diversity bias biodiversity-disease studies? 223
Finally, we tested the hypothesis that missing data at the highest and lowest diversity 224 levels in experimental and observational studies might bias studies to more commonly report 225 amplification and dilution effects, respectively. Experimental studies had a lower mean 226 maximum diversity level than observational studies (experimental mean ± sd: 25 ± 10, 227 observational mean ± sd: 76 ± 89). Thus, it appears that experimental studies are missing data at 228 the highest diversity levels, which could bias experimental studies towards amplification effects. 229
This result could emerge from two key differences between experiments and observational 230 studies. First, experimentally manipulating many species is logistically challenging at 231 high richness, potentially biasing experimental studies to include fewer total species than 232 observational studies of equivalent size. Second, the number of species in an area is highly 233 sensitive to the area surveyed (32), and observational studies were, on average, five orders of 234 magnitude larger than manipulative experiments ( Fig S3) . Focusing on studies of comparable 235 extent (1-10 km 2 ) eliminated the difference in mean maximum diversity between experiments 236 (29 ± 10) and observational studies (22.0 ± 10), supporting this second mechanism. 237
We also examined the lowest diversity levels to assess whether there was missing data at 238 low diversity. Experimental studies had lower mean minimum diversity than observational 239 studies (experimental mean ± sd: 1.2 ± 0.6), observational mean ± sd: 4.3 ± 7.3), which could 240 bias observational studies towards dilution effects. However, out of 231 studies, 84% of studies 241 included an effective species richness of two or lower. Consequently, most studies (n=193) were 242 not missing substantial data at low host diversity. This result indicates that the potential for 243 missing data at low diversity to bias the estimated relationship between biodiversity and disease 244 is quite low. 245
Even though most studies were not missing substantial data at low host diversity, we still 246 performed an additional test of the hypothesis that missing data might bias studies to more 247 commonly report dilution effects. Here, we again quantified the skew of each biodiversity-248 disease relationship, this time constraining each curve to pass through the origin because if there 249 are no hosts there cannot be any parasites. Constraining each curve to pass through the origin 250 should reduce the estimated skew in all studies, particularly studies that found monotonic 251 dilution effects. As predicted, constraining the curves to the origin significantly changed the 252 shape of the average biodiversity-disease relationship (p = 0.001), reducing the estimated 253 frequency of dilution effects and increasing the estimated frequency of amplification effects ( Fig.  254   4 ). This result indicates that ignoring missing data may bias some studies to underreport 255 amplification effects. However, even though constraining curves to fit through the origin shifted skewed (p=0.051; Fig. S4 ). Furthermore, spatial scale still significantly moderated the sign of the 258 constrained curves, with dilution more common at small scales and amplification more common 259 at large scales (p<0.0001; Fig. S5 ), and this effect was still robust to ecological characteristics of 260 individual study systems (Table S2) . 261
These results indicate that scale-dependence of the biodiversity-disease relationship is 262 robust to missing data at low diversity levels. The robustness of this scale-dependence may be a 263 product of the underlying shape of biodiversity-disease relationships. Studies that found 264 monotonic amplification effects were unlikely to be altered by missing data at low diversity ( Fig  265   1a ). Conversely, studies that found monotonic dilution had higher potential to be altered by 266 missing data at low diversity. However, 66 of the 72 studies showing monotonic dilution effects 267 included an effective species richness of two or lower. Thus, regardless of the shape of the 268 relationship between the origin and the point of peak parasite abundance, the area in which 269 amplification could occur was generally quite small. We therefore conclude that although the 270 biodiversity-disease relationship can take on many forms, and its form may depend on a 271 nonlinearity that is driven by parasite extinction at low host diversity, such nonlinearities are 272 unlikely to alter a general and common phenomenon: dilution effects most commonly occur at 273 local scales and amplification effects most commonly occur at regional scales. 274
Together, these results indicate that the scale-dependence of biodiversity-disease 275 relationships might be robust to missing data at low diversity levels and to ecological 276 characteristics of individual studies. However, we are unable to test whether missing data at high 277 diversity might bias experimental studies to more commonly observe amplification. This bias of 278 experimental studies is difficult to assess because, in most systems, the distribution of natural 279 levels of host diversity is unknown. Furthermore, a major limitation to this analysis is the lack of empirical studies conducted across spatial scales and ecological conditions using the same 281 methodologies. We are hopeful that as large-scale replicated studies, such as the Nutrient 282 Network (33) and National Environmental Observatory Network (34), become more widespread, 283 the quality of data at the largest spatial scales will improve. These results also highlight the need 284 to consider whether the scales of conservation actions and public health interventions are 285 appropriate to influence biodiversity-disease relationships in a way that will benefit humans (3, 286 27, 30). In general, these results suggest that biodiversity conservation can be beneficial to 
Selection criteria and data collection 311
We only included studies that measured parasite abundance or prevalence at more than 312 two host diversity levels. We included studies that reported infection prevalence, mean parasite 313 load, density of infected vectors, or percent diseased tissue, because these quantities are the most 314 relevant metrics of disease risk for microparasites, macroparasites, vector-borne parasites, and 315 plant parasites, respectively. We did not standardize parasite abundance, and therefore did not 316 compare parasite abundance among studies. Host biodiversity was reported as species richness, 317
Simpson's diversity index (J), or Shannon's diversity index (H). We standardize across these 318 measures to facilitate comparisons across studies by transforming diversity into the effective 319 number of species, following Jost (43). In experiments, estimated diversity included all taxa 320 added by the experimenters, while the diversity estimate in observational studies was limited to a 321 focal taxonomic or functional group of host species, defined in the primary study (e.g., 322 herbaceous plants, trees, birds, or small mammals). 323
We extracted data from text and tables manually and from figures using 324 (infecting only wildlife or also infecting humans), focal host species, associated species (i.e., 327 additional species whose presence may dilute or amplify parasite abundance, operationally 328 defined as "potential diluters"), the diversity (e.g., richness) in the treatments (or in the field 329 survey), parasite functional group (macroparasite vs. microparasite), parasite lifecycle (complex 330 vs. direct), and study design (manipulative vs. observational). Spatial extent was quantified as 331 the area (expressed in square kilometers) over which all biodiversity estimates were compared in 332 a given study. Studies rarely provided an exact value for spatial extent. Because a value for 333 spatial extent was rarely provided, and spatial extents varied by six orders of magnitude, we 334 estimated the extent of each survey to the nearest order of magnitude rather than attempting to 335 assign a specific spatial extent for each study. For example, we assigned studies a value of 0.1 if 336 the extent was less than 1 km 2 , and a value of 1 if the extent was greater than 1 km 2 , but less than 337 10 km 2 , etc. 338 339
Assessing the shape of the biodiversity-disease relationship 340
We first quantified whether each biodiversity-disease relationship was linear or nonlinear 341 by comparing a series of regression models using the lm and AIC functions in R version 3.5.0 342 (45) (see main text for methods). Four studies included fewer than five host diversity levels and 343 were therefore not tested using a third-order polynomial. Next, we quantified the monotonicity 344 and direction of each biodiversity-disease relationship using Spearman rank correlations (see 345 main text for methods). We then assessed the skew of each biodiversity-disease relationship 346 using R package cobs (46) to fit an unconstrained spline to the biodiversity-disease relationship, 347 limited to a maximum of four knots to prevent overfitting. This approach to fitting an between biodiversity and disease. We transformed the predicted curve into a frequency 350 distribution, assigning any negative value (occurring in 19 regressions) to zero, and then 351 smoothing splines (47), we added a value at the origin for each data set, corresponding to a 358 situation in which there is no host diversity, generated a constraint matrix to force the line 359 through the origin, and then fit the curve, limiting the maximum number of knots in the curve to 360 three to prevent overfitting. 361
We omitted studies with fewer than four unique measures of host diversity for Spearman 362 rank correlations and unconstrained splines and fewer than three unique measures of host 363 diversity for CQ splines. Twenty-nine of the unconstrained splines (n=231) and 39 of the CQ 364 splines (n=243) showed no relationship between biodiversity and disease (e.g., a fit with a slope 365 of zero), resulting in no estimate of Pearson's skewness. This resulted in 231 estimates of r, 202 366 estimates of skew from unconstrained splines, and 204 estimates of skew from CQ splines. 367 368
Data analysis 369
All analyses were carried out in R version 3.5.0 (45). We constructed multilevel random 370 effects models using the lmer function in R packages lme4 (48) and lmerTest (49). We accounted for nonindependence arising from multiple measures from the same observational units in the 372 same year by including such non-independent surveys as random intercepts in each model. 373
Using the model described above, we first tested whether studies exhibiting no 374 relationship, linear amplification, linear dilution, a unimodal relationship or a third-order 375 polynomial relationship predicted Spearman rank correlation and Pearson's skewness. We next 376 verified that studies exhibiting monotonic dilution, monotonic amplification, and non-monotonic 377 relationships (categorized using the Spearman rank correlation) predicted Pearson's skewness. 378
Next, we tested whether the Spearman rank correlation coefficient between biodiversity and 379 disease or Pearson's skewness were influenced by spatial extent by fitting two separate models, 380 each with one response (r or skew) and one predictor (extent). 381
We then tested for context dependence in the spatial moderation of dilution effects. To 382 test for context dependence, we fit the same two models, but included a two-way interaction 383 between spatial extent and four binary factors that might explain variation in the effects of scale 384 on the biodiversity-disease relationship: parasite functional group (macroparasite vs. 385 microparasite), parasite lifecycle (complex vs. direct), study design (manipulative vs. 386 observational), and parasite type (infects humans vs. infects only wildlife). 387
We next tested whether missing data at low and high diversity might bias studies to more 388 commonly report amplification and dilution effects. We quantified the maximum and minimum 389 diversity level of each study and compared whether the mean maximum and mean minimum 390 diversity level differed between experiments and observational studies. Because the species-area 391 relationship is nonlinear and sample area was highly variable across studies, we compared 392 minimum and maximum diversity across studies qualitatively rather than quantitatively.
To quantitatively test whether missing data at low host diversity could bias studies to 394 more commonly report dilution effects, we tested whether constraining the curves to pass 395 through the origin altered the predicted skew. Specifically, we calculated the difference in skew 396 between constrained and unconstrained curves and then performed an intercept-only model on 397 this value, where an estimate significantly lower than zero would indicate that constraining the 398 curve favored amplification, and an estimate significantly higher than zero would indicate that 399 constraining the curve favored dilution. Finally, we analyzed whether spatial scale moderated the 400 shape of the biodiversity-disease relationship when curves were constrained to pass through the 401 origin. Here, we fit a model of Pearson's skewness and spatial extent and then performed the 402 same test of context dependence on the model that was performed before. right-skewed distribution suggests that dilution might occur more frequently, but less intensely 525 than amplification because the relationship is moderately negative over a greater portion of the 526 biodiversity gradient than it is strongly positive. A non-monotonic left-skewed distribution 527 suggest that amplification might occur more frequently but less intensely than dilution, because 528 the relationship is moderately positive over a greater portion of the biodiversity gradient than it is 529 strongly negative. A monotonic and asymptotic distribution suggests that amplification becomes 530 increasingly moderate with biodiversity. B) In addition to the shape of biodiversity-disease 531 relationships, the location on the curve where biodiversity levels are observed will also affect the 532 likelihood and intensity of dilution and amplification. For example, in a left-skewed biodiversity-533 disease relationship, collecting measurements at biodiversity beyond the peak of parasite 534 abundance could lead researchers to conclude that there is was a linear dilution effect, whereas 535 measurements before the peak of parasite abundance would lead researchers to conclude that 536 there was a linear amplification effect. 537 
